Canonical text (the exact bytes fingerprinted)

TRUVACE RECORD VERSION
record: TRV-2026-1896
version: 1
kind: certified
reason: Certified into the record
timestamp: 2026-10-19T10:42:28.399992Z
status: published
lens: g_space
sector: health
headline: Enhancing Liver Cirrhosis Diagnosis Using Machine Learning With Explainable AI and Cross-Validated Hyperparameter Tuning Techniques
dek: Cirrhosis is a form of Chronic Liver Disease (CLD) resulting from sustained liver damage from several causes, including viral infection, autoimmune disorders, cholestatic and metabolic disease Non-Alcoholic Fatty Liver Disease (NAFLD) or heavy alcohol use. Testing for the presence of Liver Cirrhosis (LC) is one of the most critical diagnostics and prognostic assessments for patients. Detecting liver illness in its early stages is challenging as initial symptoms are often mild and difficult to diagnose. Cirrhosis…
gain_title: An XGBoost classifier paired with explainable AI diagnosed liver cirrhosis at 91.19% accuracy on a cirrhosis dataset under 10-fold cross-validation, and the explanations aim to make model decisions transparent to clinicians.
problem_title: (none)
trace_subject: (none)
gain_reading: An XGBoost classifier paired with explainable AI diagnosed liver cirrhosis at 91.19% accuracy on a cirrhosis dataset under 10-fold cross-validation, and the explanations aim to make model decisions transparent to clinicians.
gain_evidence: The proposed method has achieved significantly 91.19% using XGBoost for cirrhosis dataset with K-fold validation(K=10) approach.
problem_reading: (none)
problem_evidence: (none)
quick_read: Researchers designed and tested a non-invasive diagnostic model for liver cirrhosis that combines an XGBoost classifier with explainable AI. They compared it against several other machine learning models and report that it performed best, reaching 91.19% on a cirrhosis dataset using ten-fold cross-validation.

Cirrhosis often stays silent until it is advanced, so earlier and more trustworthy detection could matter for patients. The explainability component targets clinician distrust of opaque models, but the abstract gives no detail on data source, external validation, or use in real clinical practice.
limitation: The abstract reports results only on a cirrhosis dataset using cross-validation and gives no evidence of testing in clinical settings, so real-world diagnostic performance remains unestablished.
tag: Evidence-backed gain
key_points: The model combines an XGBoost classifier with an explainable AI framework for cirrhosis diagnosis. | It was evaluated with 10-fold cross-validation and reached 91.19% on a cirrhosis dataset. | The authors report it outperformed various other machine learning models. | Explainability is meant to expose decision reasoning and thereby guide treatment strategies.
rundown: Cirrhosis is a form of chronic liver disease caused by sustained liver damage from viral infection, autoimmune disorders, cholestatic and metabolic disease, non-alcoholic fatty liver disease, or heavy alcohol use. Early symptoms are often mild, so detection in the early stages is difficult.

The source argues that complex models lack explanations for their decisions, which creates clinician distrust. The study responds by adding explainable AI to make the reasoning behind predictions visible.

The proposed approach is described as non-invasive and was assessed against various machine learning models, with the authors reporting superior results.
sources:
- peer_reviewed | International Journal of Advanced Research in Science Communication and Technology | https://doi.org/10.48175/ijarsct-38937 | 2026-10-18
prev: 0000000000000000000000000000000000000000000000000000000000000000

sha256

53586f8b80c8ae1d541c42b25fa147dad118d5b43dc7e47184439c28ca51ca0e

previous

0000000000000000000000000000000000000000000000000000000000000000